112 related articles for article (PubMed ID: 17984310)
1. Daily cyclophosphamide for scleroderma: are patients with the most to gain underrepresented in this trial?
Wells AU; Latsi P; McCune WJ
Am J Respir Crit Care Med; 2007 Nov; 176(10):952-3. PubMed ID: 17984310
[No Abstract] [Full Text] [Related]
2. Adverse events during the Scleroderma Lung Study.
Furst DE; Tseng CH; Clements PJ; Strange C; Tashkin DP; Roth MD; Khanna D; Li N; Elashoff R; Schraufnagel DE;
Am J Med; 2011 May; 124(5):459-67. PubMed ID: 21531236
[TBL] [Abstract][Full Text] [Related]
3. A multicenter, prospective, randomized, double-blind, placebo-controlled trial of corticosteroids and intravenous cyclophosphamide followed by oral azathioprine for the treatment of pulmonary fibrosis in scleroderma.
Hoyles RK; Ellis RW; Wellsbury J; Lees B; Newlands P; Goh NS; Roberts C; Desai S; Herrick AL; McHugh NJ; Foley NM; Pearson SB; Emery P; Veale DJ; Denton CP; Wells AU; Black CM; du Bois RM
Arthritis Rheum; 2006 Dec; 54(12):3962-70. PubMed ID: 17133610
[TBL] [Abstract][Full Text] [Related]
4. Effects of 1-year treatment with cyclophosphamide on outcomes at 2 years in scleroderma lung disease.
Tashkin DP; Elashoff R; Clements PJ; Roth MD; Furst DE; Silver RM; Goldin J; Arriola E; Strange C; Bolster MB; Seibold JR; Riley DJ; Hsu VM; Varga J; Schraufnagel D; Theodore A; Simms R; Wise R; Wigley F; White B; Steen V; Read C; Mayes M; Parsley E; Mubarak K; Connolly MK; Golden J; Olman M; Fessler B; Rothfield N; Metersky M; Khanna D; Li N; Li G;
Am J Respir Crit Care Med; 2007 Nov; 176(10):1026-34. PubMed ID: 17717203
[TBL] [Abstract][Full Text] [Related]
5. Cyclophosphamide in systemic sclerosis: light and shadows.
Vlachoyiannopoulos PG; Ioannidis JP
Clin Exp Rheumatol; 2004; 22(5):551-2. PubMed ID: 15485005
[No Abstract] [Full Text] [Related]
6. Pulse cyclophosphamide decreases sympathetic postganglionic activity, controls alveolitis, and normalizes vascular tone dysfunction (Raynaud's phenomenon) in a case of early systemic sclerosis.
Casale R; Generini S; Luppi F; Pignone A; Matucci-Cerinic M
Arthritis Rheum; 2004 Aug; 51(4):665-9. PubMed ID: 15334442
[No Abstract] [Full Text] [Related]
7. Cyclophosphamide pulse regimen in the treatment of alveolitis in systemic sclerosis.
Mittal G; Udwadia Z; Joshi VR
J Rheumatol; 2003 May; 30(5):1121-2; author reply 1122. PubMed ID: 12734923
[No Abstract] [Full Text] [Related]
8. Elevated levels of leukotriene B4 and leukotriene E4 in bronchoalveolar lavage fluid from patients with scleroderma lung disease.
Kowal-Bielecka O; Distler O; Kowal K; Siergiejko Z; Chwiećko J; Sulik A; Gay RE; Łukaszyk AB; Gay S; Sierakowski S
Arthritis Rheum; 2003 Jun; 48(6):1639-46. PubMed ID: 12794832
[TBL] [Abstract][Full Text] [Related]
9. Intravenous cyclophosphamide therapy for systemic sclerosis. A single-center experience and review of the literature with pooled analysis of lung function test results.
Airò P; Danieli E; Parrinello G; Antonioli CM; Cavazzana I; Toniati P; Franceschini F; Cattaneo R
Clin Exp Rheumatol; 2004; 22(5):573-8. PubMed ID: 15485010
[TBL] [Abstract][Full Text] [Related]
10. Cyclophosphamide reduces neutrophilic alveolitis in patients with scleroderma lung disease: a retrospective analysis of serial bronchoalveolar lavage investigations.
Kowal-Bielecka O; Kowal K; Rojewska J; Bodzenta-Lukaszyk A; Siergiejko Z; Sierakowska M; Sierakowski S
Ann Rheum Dis; 2005 Sep; 64(9):1343-6. PubMed ID: 16100339
[TBL] [Abstract][Full Text] [Related]
11. High-dose prednisolone and bolus cyclophosphamide in interstitial lung disease associated with systemic sclerosis: a prospective open study.
Wanchu A; Suryanaryana BS; Sharma S; Sharma A; Bambery P
Int J Rheum Dis; 2009 Sep; 12(3):239-42. PubMed ID: 20374353
[TBL] [Abstract][Full Text] [Related]
12. [Treatment of interstitial pulmonary fibrosis with D-penicillamine in progressive scleroderma: a long-term study (author's transl)].
Bröll H; Tausch G; Eberl R
Wien Klin Wochenschr; 1976 Apr; 88(9):292-5. PubMed ID: 973388
[TBL] [Abstract][Full Text] [Related]
13. Lung fibrosis in systemic sclerosis treated with a combination of ciclosporin and azathioprine.
Hider SL; Woodhead M; Taylor PM; Bruce IN
Clin Exp Rheumatol; 2006; 24(2):215. PubMed ID: 16762168
[No Abstract] [Full Text] [Related]
14. Educational case report - self assessment.
Walker T
Cytopathology; 2002 Oct; 13(5):329. PubMed ID: 12421450
[No Abstract] [Full Text] [Related]
15. Cyclophosphamide and low-dose prednisone therapy in patients with systemic sclerosis (scleroderma) with interstitial lung disease.
Silver RM; Warrick JH; Kinsella MB; Staudt LS; Baumann MH; Strange C
J Rheumatol; 1993 May; 20(5):838-44. PubMed ID: 8336309
[TBL] [Abstract][Full Text] [Related]
16. [Cyclophosphamide pulse therapy for pediatric systemic sclerosis].
Iwata N; Miyamae T; Imagawa T; Katakura S; Mori M; Aihara Y; Yokota S; Kondo M; Sasaki T; Ikezawa Y
Ryumachi; 2003 Oct; 43(4):660-6. PubMed ID: 14598659
[TBL] [Abstract][Full Text] [Related]
17. Bronchoalveolar cellular analysis in scleroderma lung disease: does Sutton's law hold?
Baughman RP; Raghu G
Am J Respir Crit Care Med; 2008 Jan; 177(1):2-3. PubMed ID: 18096712
[No Abstract] [Full Text] [Related]
18. [Pulmonary arterial hypertension in collagen disease: experiences of the German Network for Systemic Scleroderma].
Hunzelmann N; Riemekasten G
Dtsch Med Wochenschr; 2006 Dec; 131(49 Suppl 9):S325-7. PubMed ID: 17139598
[TBL] [Abstract][Full Text] [Related]
19. Autologous HSCT in systemic sclerosis: a step forward.
Farge D; Gluckman E
Lancet; 2011 Aug; 378(9790):460-2. PubMed ID: 21777973
[No Abstract] [Full Text] [Related]
20. Effect of monthly cyclophosphamide pulses on skin sclerosis in systemic sclerosis.
Khader A; Valiaveetil B; Nalini SD; George B; Sasidharanpillai S; Nazeer MMA; Manikath N
Indian J Dermatol Venereol Leprol; 2021; 87(5):728-731. PubMed ID: 34379952
[No Abstract] [Full Text] [Related]
[Next] [New Search]
